What disease-modifying treatments are commonly used for Guillain-Barré syndrome?

Prepare for the Registered Respiratory Therapist CSE with comprehensive flashcards and multiple-choice questions, including hints and explanations. Ace your exam with confidence!

Multiple Choice

What disease-modifying treatments are commonly used for Guillain-Barré syndrome?

Guillain-Barré syndrome is an acute immune‑mediated neuropathy, so the treatments that truly modify the disease course are those that blunt or redirect the immune attack on the nerves. Plasmapheresis (plasma exchange) and intravenous immunoglobulin (IVIG) work by removing or neutralizing circulating antibodies and inflammatory mediators or by modulating the immune response. When given early, these therapies shorten recovery time and improve outcomes, and they are considered first-line disease-modifying treatments for GBS because of their similar efficacy. Broad-spectrum antibiotics don’t alter the autoimmune process of GBS; they’re used only if an infection is present, and they don’t change the disease trajectory. Corticosteroids alone have not consistently shown benefit in changing the course of GBS, so they’re not effective as the main disease-modifying therapy. Continuous dialysis isn’t a treatment for the underlying immune-mediated nerve injury, though it may be necessary for unrelated kidney issues. So, the best answer reflects the standard disease-modifying options: plasmapheresis and IVIG.

Guillain-Barré syndrome is an acute immune‑mediated neuropathy, so the treatments that truly modify the disease course are those that blunt or redirect the immune attack on the nerves. Plasmapheresis (plasma exchange) and intravenous immunoglobulin (IVIG) work by removing or neutralizing circulating antibodies and inflammatory mediators or by modulating the immune response. When given early, these therapies shorten recovery time and improve outcomes, and they are considered first-line disease-modifying treatments for GBS because of their similar efficacy.

Broad-spectrum antibiotics don’t alter the autoimmune process of GBS; they’re used only if an infection is present, and they don’t change the disease trajectory. Corticosteroids alone have not consistently shown benefit in changing the course of GBS, so they’re not effective as the main disease-modifying therapy. Continuous dialysis isn’t a treatment for the underlying immune-mediated nerve injury, though it may be necessary for unrelated kidney issues.

So, the best answer reflects the standard disease-modifying options: plasmapheresis and IVIG.

More practice questions